Valiant Organics closes trading window from October 1 ahead of Q2FY27 results
- Trading window closes for insiders starting October 1, 2026
- Restriction applies until 48 hours after Q2FY27 results declaration
- Covers Directors, Promoters, Designated Persons, and Connected Persons
- Compliance mandated by SEBI (Prohibition of Insider Trading) Regulations, 2015

*this image is generated using AI for illustrative purposes only.
Valiant Organics Limited will close its trading window for dealing in securities starting Thursday, October 1, 2026. This measure restricts insiders from trading until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026.
The company notified the BSE and National Stock Exchange of India Limited regarding this closure. The restriction applies to all Directors, Promoters, Promoter Group members, Designated Persons, their immediate relatives, and Connected Persons. This action is taken pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Regulatory Compliance Details
The trading window closure is implemented in accordance with the Company's Code of Conduct for the Prevention of Insider Trading. The notification was signed by Kaustubh Bhalchandra Kulkarni, Company Secretary, on September 28, 2026. The filing references the specific regulatory framework governing insider trading restrictions for listed entities in India.
| Item | Detail |
|---|---|
| Window Closure Start | October 1, 2026 |
| Window Reopening | 48 hours post Q2FY27 results |
| Reporting Period | Quarter and half year ended September 30, 2026 |
| Governing Regulation | SEBI (Prohibition of Insider Trading) Regulations, 2015 |
This procedural step ensures that no sensitive price-sensitive information is misused during the period leading up to the public announcement of the company's financial performance.
Historical Stock Returns for Valiant Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.09% | -6.77% | +36.08% | +68.27% | +15.96% | 0.0% |
How might Valiant Organics' Q2 FY27 financial results influence its stock volatility upon the trading window reopening?
What are the potential impacts of the upcoming results on Valiant Organics' debt covenants or credit rating?
Are there any pending regulatory approvals or strategic partnerships expected to be disclosed alongside the Q2 results?
































